Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs KERNX Health

CoreAge Rx
Graded #1

Higher grade

vs+20
KERNX Health
Graded #101

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 71.8/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +18
92
74
Dose & formulationCoreAge Rx +20
88
68
Clinical oversightCoreAge Rx +11
93
82
Labs & monitoringCoreAge Rx +35
90
55
FulfillmentCoreAge Rx +27
95
68
Contract termsCoreAge Rx +10
96
86
CoreAge Rx · left barKERNX Health · right bar

The numbers

MetricCoreAge RxKERNX Health
WeighScore91.8/10071.8/100
GradeA−C
Scorecard rank#1#101
Semaglutide$99/mo$129/mo (compounded, plus a one-time consultation fee)
Tirzepatide$149/mo$229/mo (compounded, plus a one-time consultation fee)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
KERNX Health

Graded #101 · C

Strengths

  • Prescribing clinicians are listed by name and credential rather than described as an anonymous "licensed provider network"
  • A provider approves treatment before any charge is processed, and the site states plainly when it is not the right fit
  • Monthly provider check-ins and a care team reachable seven days a week are included in the plan rather than sold as an upgrade
  • The dose ladder is published for both molecules, so a dose escalation has a known price attached before it happens

Where it loses points

  • The dispensing pharmacy is disclosed only in post-purchase paperwork, so no 503A or 503B status can be checked before you commit
  • Lab work is not part of the program: it is recommended case by case, billed separately, and may be sent to your own provider
  • Explicitly no health coaching or behavioral support — clinical oversight only
  • Injectable compounded medication only, with no oral route and no FDA-approved brand pathway
  • Cash-pay only, so nothing routes through insurance and no claim can be submitted for you

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard